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Review
As we begin the second decade of the 21st 
century, environmental science and environ-
mental health science are well-defined fields of 
research. For instance, environmental science 
includes understanding the sources of toxicants 
and the processes that release and transport 
them though air, water, soil, or food and has 
applications to sustainability. Environmental 
health science describes the processes and effects 
that occur after the human body has received 
a toxicant, including mechanistic research in 
toxicology as well as epidemiology or clinical 
practice. However, neither environmental sci-
ence nor environmental health science directly 
addresses the fundamental issues of whether 
and how human contact with toxicants occurs 
after release into the environment or workplace.
The relatively new field of exposure sci-
ence provides information and tools to bridge 
or to directly link the above disciplines by 
quantifying and characterizing the conditions 
for contact with toxicants. For example, after 
a chemical, physical, or biological toxicant 
enters an environmental medium (e.g., by 
atmospheric dispersion), if a person’s behav-
ior or activities puts him or her in contact 
with the toxicant, the human body can be 
exposed through inhalation, ingestion, or der-
mal route. Subsequently, the material can be 
absorbed or adsorbed, resulting in a dose and 
potentially a disease outcome. The importance 
of exposure science in defining those links and 
protecting public health, however, is still not 
universally understood. Clearly, throughout 
the second half of the 20th century, workers 
began to be protected by wearing personal 
protective equipment (PPE) or adding near-
field engineering or administrative controls 
on the source. In contrast, PPE is not a norm 
in environmental settings. Thus, exposure sci-
ence is essential for eliminating or reducing 
contacts with toxicants or for altering people’s 
activities/habits before a problem arises. The 
applications within environmental settings are 
more complex than for occupational settings, 
including the fact that toxicant concentrations 
are usually much lower. In this review I pro-
vide information on the status of the field and 
my insights on what needs to be accomplished 
to make the field more visible and make the 
research results more usable by a wide range of 
scientific disciplines and policy makers.
In 1987 the first National Research 
Council (NRC) Committee on Exposure met 
to discuss inhalation exposure to air pollution. 
It was partly an outgrowth of research con-
ducted in the Harvard Six Cities study and in 
indoor air pollution issues, for example, envi-
ronmental tobacco smoke and radon (Dockery 
et al. 1993; NRC 1981). The recommenda-
tions of the multidisciplinary NRC committee 
set forth new research directions, and the eval-
uation also helped define the core principles 
for the entire field of exposure. The activities 
of the committee accelerated the birth of the 
International Society of Exposure Science as 
well as a scientific journal focused on exposure 
(NRC 1991). At the time, exposure assessment 
had been considered only a practical analysis 
tool invented primarily to support the field 
of risk assessment (NRC 1983). However, 
the actual roots of the field could be found in 
industrial and occupational hygiene (Gochfeld 
2005; Harris 2000). Further, the general con-
cept of contact with a toxic agent can be traced 
back even deeper into the history of occupa-
tional medicine, with the qualitative aspects 
of exposure being traceable to the treatise 
De Morbis Articum written by Ramazzini in 
1688 (Lioy 2007; Ramazzini 1964). The main 
concept derived from occupational/industrial 
hygiene was the need to focus on personal con-
tact with the toxicant of concern.
The work of the committee solidified a 
basic equation of exposure:
  E = ∫
t1
to C(t)dt,  [1]
which showed that exposure (E) is a func-
tion of both concentration (C) and intervals 
of time (dt), but the form can also be a lin-
ear summation of discrete exposures (NRC 
1991). However, the most important point 
is that duration and frequency of exposure 
must also be coupled to a biologically relevant 
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time of contact for any disease outcome before 
E can have any meaning in terms of defin-
ing human exposure–response relationships. 
Thus, exposure science must consider toxico-
logic and epidemiologic information to focus 
hypotheses. This is understandable, because 
the types of contacts that are important for 
determining the potential for long-term effects 
will not necessarily be the same as those for 
acute effects.
During the NRC discussions, I published 
an article on the concepts of source to dose, 
showing the central role human exposure has 
in linking traditional environmental science 
with the fields of toxicology, epidemiology, 
and risk assessment (Lioy 1990). The article 
included a process continuum from source 
to human health that focused on the loca-
tion of the field within the environment and 
health processes. It did not provide details on 
each field to the left and the right of exposure 
science (the most recent revision of the con-
tinuum is shown in Figure 1), but identifies 
major processes and points to issues of risk 
management and prevention.
In 1990, Wayne Ott published a paper 
on exposure assessment research at the U.S. 
Environmental Protection Agency (EPA) (Ott 
1990). An update (Lioy 1999) built on the 
work of others, including the ideas presented 
in the article on the “birth of a new science” 
(Ott 1995). These and other events were 
summarized recently in my editorial “Time 
for a Change: From Exposure Assessment to 
Exposure Science” (Lioy 2008).
The definition of exposure science was 
published in the Journal of Exposure Science 
and Environmental Epidemiology by Dana Barr 
(2006): 
It studies human contact with chemical, physical 
or biological agents occurring in their environ-
ments, and advances knowledge of the mecha-
nisms and dynamics of events either causing or 
preventing adverse health outcomes.
Today the field is at a crucial juncture in its 
development, as the need for exposure-related 
research is expanding throughout the world 
(Barr 2006; Lioy et al. 2005; Sheldon and 
Cohen-Hubel 2009; Weis et al. 2005; Wilson 
and Suk 2005). However, the resources and 
funding required to support the science are 
still inadequate when compared with resources 
provided for the other components of envi-
ronmental health sciences. For example, in 
the United States, the National Institute of 
Environmental Health Sciences (NIEHS, per-
sonal communication) is funded at a level of 
> $680 million year, but its Exposure Biology 
Program, a special initiative on a subgroup 
of exposure research needs, totals only about 
$30 million. Similarly, the National Exposure 
Research Laboratory (NERL) of the U.S. EPA 
is funded only at a level of about $50 million/
year (EPA-NERL, personal communication). 
These numbers indicate significant underfund-
ing of the field and probably reflect the situa-
tion throughout the world. Further, to move 
the field forward during the first half of the 
21st century, both the number of exposure 
science professionals and their skill sets must 
expand beyond what was sufficient for the past 
25 years. However, in contrast to toxicology, 
there is no federally funded training program 
dedicated primarily to this component of envi-
ronmental health science, despite its potential 
to serve as a transdisciplinary bridge between 
hazardous wastes, nanotechnology, consumer 
products, sustainability, alternate fuels and 
energy, and other critical research areas.
The lack of a steady stream of investigators 
coming into the field is also a problem for pro-
posal submissions and review. Basically, there 
are not enough peers on grant and contract 
review panels to provide a balanced evaluation 
of exposure science proposals, which are often 
inappropriately reviewed as if they were envi-
ronmental science or toxicologic studies. This 
results in a lack of understanding of exposure 
science research and a hesitancy to fund proj-
ects that advance the field. Without adequate, 
dedicated training programs and funding 
mechanisms, it will be difficult to increase the 
recognition of the utility of exposure science; 
consequently, future risk assessments and 
other applications will still have major gaps in 
exposure information. Further, if the concept 
of the “exposome”—“all environmental expo-
sures from conception onwards (including 
exposures from diet lifestyle, and endogenous 
sources) as a quantity of critical interest to 
disease etiology”—continues to evolve, inves-
tigators in the field will need more skill sets 
to ensure that there are tools and approaches 
available to integrate and interpret different 
types of data (Wild 2005).
Perspective on Research
With the above in mind, current and future 
scientific research issues for the field include 
the identification and evaluation of popula-
tions in contact with toxicants in countries 
around the world and development of new 
technologies and biomarkers to more accu-
rately characterize exposures and solve prob-
lems by reducing or preventing exposure. For 
each, the needs include better measurement 
and analytical equipment, human behavior 
and activity pattern analyses, automated sen-
sors, robotics, field simulations of exposure, 
and source-to-exposure and dose-modeling 
systems. The last three tools are important 
because of the increasing levels of scrutiny 
being applied to all human studies before 
approval is granted, including exposure stud-
ies, by institutional review boards associ-
ated with agencies and universities. Specific 
examples include a) measuring or simulat-
ing exposures that can occur among toddlers, 
pregnant women, or the elderly, because it 
is difficult to conduct multiroute personal 
monitoring on such subjects (Lebowitz et al. 
2008; Shalat et al. 2007; U.S. EPA 2008c); 
Figure 1. Process continuum from contaminant emissions to a health effect and application to risk reduction and prevention strategies (adapted from Lioy 1990, 1999).
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and b) augmenting the tools being developed 
in chemical toxicity testing with a parallel 
set of tools that can be used to detect low 
levels in the community and prioritize expo-
sures for subsequent application in risk assess-
ment (Cohen Hubal et al. 2010; Sheldon and 
Cohen-Hubel 2009). These are areas where 
innovation can improve our ability to address 
critical environmental health issues.
Observational studies of human expo-
sure. Many types of studies of human expo-
sure have included laboratory analyses and 
computer simulation modeling. However, 
the growth of the field truly began with the 
design and completion of field studies. In the 
1980s many of the important hypotheses and 
applications were associated with observa-
tional studies (Wallace et al. 1986). This was 
not surprising, because the collection of per-
sonal monitoring and biological monitoring 
samples provided basic information on con-
tact with toxic materials. Observational stud-
ies were warranted at the time, with many 
of the initial projects associated with reduc-
ing exposure to indoor air pollution (NRC 
1981). However, there was also a significant 
engineering influence on the field because of 
the need for ventilation to at least reduce the 
levels of air pollutants indoors. The definition 
of observational studies for the purposes of 
characterizing human exposure is the collec-
tion of personal environmental samples, data, 
and information from participating volun-
teers in their everyday environments as they 
go about their normal activities.
A key part of this definition is that inves-
tigators do not purposely expose a subject or 
volunteers to anything not present or used 
in their everyday environment. The investi-
gators are passively involved in the lives of 
the subjects from which they collect samples 
and data on the chemical, physical, and bio-
logical world around them. Programs such as 
the Total Exposure Assessment Methodology 
(TEAM) studies (many types and loca-
tions) and The National Human Exposure 
Assessment Survey (NHEXAS) were designed 
and completed in the United States to acquire 
such information on how people come in 
contact with toxicants (Clayton et al. 1993; 
Pellizzari et al. 1995; Sexton et al. 1995; 
Wallace et al. 1986). These two studies, as 
well as other exposure studies conducted 
around the world, helped establish a baseline 
on multiroute and multipathway exposures to 
environmental contaminants (Cohen-Hubal 
et al. 2000; Hoffmann et al. 2000a, 2000b; 
Jantunen et al. 1998; Korrick et al. 2000; 
Weisel et al. 2005; Williams et al. 2000a, 
2000b). They provided data needed to reduce 
uncertainties in the characterizations of expo-
sure and identified ways to reduce exposure—
for example, dust control, home repairs, 
product replacement, and revised regulatory 
strategies. For those in epidemiology and 
medicine, such studies represented the types 
of exposure science investigations that are 
needed to test hypotheses. Subsequently, the 
information can be used to improve popula-
tion- and individual-based human exposure–
health response investigations.
The U.S. Food Quality Protection Act 
(FQPA 1996), passed in 1996, provided new 
reasons for conducting observational exposure 
studies (U.S. EPA 2008a). These studies are 
designed within a framework for evaluating 
aggregate exposure or cumulative exposures. 
The specific focus of the FQPA was pesticides, 
but the regulations can be used to evaluate 
many other toxicants. As defined, aggregate 
exposure is the extent of contact and exposure 
of a defined population to a given chemical by 
all relevant routes and all relevant sources, and 
cumulative exposure is the extent of contact or 
exposure of a defined population to multiple 
chemicals with common toxic effects found 
in at least one media and one or more sources 
(U.S. EPA 2001, 2003). However, specific 
exposure routes have often been prematurely 
discounted, which can lead to errors. Thus, 
both mechanistically based observational 
studies as well as controlled exposure studies 
need to ensure that the routes of exposure 
are selected wisely to characterize population-
based aggregate and cumulative exposure and 
human exposure–response studies.
Human behavior and activities. Research 
on human behavior or activities is an essential 
component of modern and future exposure 
science. Both mechanistic and field studies 
have been necessary to reduce uncertainties 
in levels of exposure for a compound or class 
of compounds. Included are contacts that can 
lead to inhalation exposures to resuspendable 
materials, for example, athletic activities on 
turf (grass or artificial).
Current observational studies of personal 
contact with pollutants are being augmented 
by tools that truly set exposure science apart 
from environmental science or environmen-
tal quality, namely, the mechanistic studies 
of human activity patterns and behavior in 
adults and children (Freeman et al. 1997; 
Klepeis et al. 2001; Reed et al. 1999; Schwab 
et al. 1991; Zartarian et al. 1997).
Historically, questionnaires have been 
employed in both occupational and envi-
ronmental epidemiologic studies and studies 
of human behavior (Lebowitz et al. 1989). 
Questionnaires will always have a place in 
observational exposure research and are aug-
mented by data sets with anecdotal observa-
tions and case reports of significant exposures. 
Information on activity and behavior from 
these sources were qualitative or semiquan-
titative in nature. Then investigators devel-
oped a new set of tools based on daily diaries 
and then videotaping of subjects. The results 
were digitized for quantitative analysis of 
activities and behaviors associated with con-
tinuous or periodic exposure (Freeman et al. 
1997, 2001a, 2001b; Ko et al. 2007; Rodes 
et al. 2001; Royster et al. 2002; Schwab et al. 
1991; Zartarian et al. 1997). Each tool has 
been used to improve observational exposure 
studies and information in the U.S. EPA’s 
Exposure Factors Handbook (under revision), 
which is used as a resource by risk assessors or 
managers (Moya and Phillips 2002; U.S. EPA 
1997). Shalat et al. (2007) have employed 
these data to develop the Pre-toddler Inhalable 
Particulate Environmental Robotic sampler 
(PIPER). It mimics the activities of toddlers 
and young children in locations where actual 
exposure to toxicants may occur and avoids 
the use of actual personal monitoring of a 
toddler in an exposure situation, for example, 
to residential pesticides. This is an impor-
tant advance, because the use of toddlers in 
personal monitoring studies has been ques-
tioned and has led to an ethics controversy 
summarized by Barrett (2009). It also led to 
the publication of new ethics guidelines for 
observational exposure studies in general by 
the U.S. EPA (2008c). PIPER and similar 
innovative tools could advance the field by 
minimizing concerns about conducting per-
sonal exposure studies on toddlers and could 
be an effective tool for inhalation and dermal 
exposure analyses in epidemiologic studies.
A national database, the Consolidated 
Human Activity Database (CHAD), is avail-
able for large population-exposure model 
simulations (McCurdy et al. 2000). This semi-
quantitative information is used to improve 
the accuracy of exposure characterizations and 
identify individuals and populations at highest 
risk for exposure. However, these data are not 
situation specific and may not apply to sentinel 
populations, for example, pregnant women.
Global positioning system (GPS) is a tool 
that can help track subjects in observational 
exposure studies (Elgethun et al. 2007). These 
data can be used as inputs to exposure models 
to understand the significance of human activi-
ties and behaviors on contact and estimate dis-
tributions of exposure. GPS data are coupled 
with personal monitoring, microenvironmental 
monitoring, and activity-pattern data (Duan 
1991; Georgopoulos et al. 2006; Glen et al. 
2008; Isakov et al. 2007; McKone 1991; Price 
and Chaisson 2005; Roy et al. 2003; U.S. EPA 
1992; van Wendel de Joode et al. 2005).
Biomonitoring. Biomonitoring has 
become a component of observational expo-
sure characterization in the United States and 
other countries (Barr et al. 2005; Henderson 
et al. 1992; Hoffmann et al. 2000a; Maier 
et al. 2004). At the same time, biological 
exposure indices (BEIs) are used routinely 
to augment the threshold limit value guide-
lines to identify a worker exposed to toxicants Lioy et al.
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by analyzing biological specimens [American 
Conference of Governmental Industrial 
Hygienists (ACGIH) 2009].
Biomonitoring is used by the Centers for 
Disease Control and Prevention (CDC) to pro-
vide a baseline of body burden within the gen-
eral population for > 100 organic substances 
and for trace elements (CDC 2009; Kieszak 
et al. 2002). The distributions of these agents 
are listed periodically and provide information 
on the prevalence of various toxicants released 
into the air, water, soil, and food that enter 
the body by one or more routes of exposure. 
Biomonitoring information is an integral part 
or sum of the contributions from one or more 
routes of exposure. Clearly, the dose measured 
depends on the biological sampling media. For 
example, breath analysis is used to examine 
the levels of a toxicant within a short period 
of time after exposure, which would include 
short-lived or quickly metabolized toxicants. 
In contrast, measurements of toxicants in the 
urine or blood provide information on the 
body burden that occurred for compounds that 
can pass though the body relatively quickly or 
compounds that are stored or metabolized over 
a much longer period of time (Henderson et al. 
1992). Biomonitoring data simply indicate 
that a person has been exposed, unless other 
data are provided to help determine the routes 
and pathways of exposure. The success of the 
exposome concept will be contingent partially 
on the successful linkage of these components 
of exposure science (Wild 2005).
Source-to-dose models will help unravel 
external exposure and internal dose in the 
future as more pharmacokinetics information 
is used to develop inverse-modeling tools 
(Georgopoulos et al. 2009; Mosquin et al. 
2009). The goal is to reconstruct the inten-
sity and routes of exposure for the toxicant of 
concern and ultimately the source. Analyses 
can be completed for various systems and bio-
logical markers using a carefully selected suite 
of variables from those shown in Figure 2. A 
significant scientific breakthrough will occur 
when the appropriate variables are measured 
simultaneously with biomarkers, and the results 
are routinely used to reconstruct the route of 
exposure with reasonable levels of certainty 
(Georgopoulos et al. 2009; Mosquin et al. 
2009; Roy and Georgopoulos 1998). Such data 
sets and associated analyses will be essential for 
streamlining risk-reduction strategies.
From the preceding, one can identify at 
least six possible purposes of observational data, 
including 
•	Identifying	sources	(e.g., lead from battery-
powered vehicles, mosquito misters)
•	Selecting sentinel populations (e.g., pregnant 
women)
•	Identifying the highest-exposed individuals
•	Defining the activities and behaviors that 
yield exposures
•	Defining the magnitude and frequency of 
exposure
•	Identifying exposure–response relationships.
These types of data are necessary to improve 
the results of epidemiologic studies and uncer-
tainties in risk assessments.
Exposures measured for these six purposes 
capture Wayne Ott’s fundamental exposure 
variable: contact that occurs with a toxi-
cant in any setting that a person encounters 
throughout the day (Ott 1995). Contact is 
an essential component of the source-to-dose 
continuum and must be a design issue for 
both mechanistic and field studies in exposure 
science. Observational studies must establish 
contact frequency, duration, and intensity of 
exposure agents of concern. The statement by 
Ott is very important, and I can easily explain 
it for the field by augmenting the famous 
phrase coined by Paracelsus—“The dose makes 
the poison”—to read, “The exposure provides 
the dose that makes the poison.” This con-
cept is essential for improving efficiency of risk 
management of toxicants and for fully estab-
lishing the place of exposure science within 
the disciplines associated with environmental/
occupational sciences (Figure 1).
Exposure and other modeling. Exposure 
models have evolved from models used in the 
environmental sciences and have been extended 
to dose estimation by employing pharmaco-
kinetic processes. They have been designed to 
define population exposures as well as indi-
vidual personal exposures (Arnold and Price 
2007; Duan 1991; Georgopoulos and Lioy 
2006; Graham and McCurdy 2004; Jayjock 
et al. 2007; McKone 1991; Ott et al. 2007; 
U.S. EPA 2009). Thus, exposure models and 
systems use models from other fields, such as 
those that estimate the movement of pollutants 
through the environment, and human activ-
ity and physiology (Anderson and Woessner 
1992; Zannetti 1990).
Forward-direction prognostic models 
developed in exposure science can be used to 
either generate hypotheses or test the valid-
ity or the utility of observational studies to 
Figure 2. A source-to-dose modeling system: MENTOR/DORIAN (adapted from Georgopoulos 2008). 
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represent exposures to larger populations or 
to evaluate the validity of the measurement 
results. A schematic representation of the 
entire system of variables from source to dis-
ease is found in Figure 2. This approach can 
be simplified to address specific problems. The 
general process can focus exploratory studies to 
examine various relationships and design new 
laboratory or field studies to generate as well 
as test hypotheses on exposure and exposure–
response relationships. However, resources 
need to be provided to develop such tools and 
to engage toxicologists in the selection of the 
most important acute long-term effects in 
order to help improve risk assessment.
Results from individual observational expo-
sure studies are often used to generalize results 
to larger populations using statistical and dis-
tributional modeling of exposures. Examples 
include the U.S. EPA’s Stochastic Human 
Exposure and Dose Simulation (SHEDS) and 
LifeLine (Burke et al. 2001; LifeLine Group 
2007; Price et al. 2003; Zartarian et al. 2006, 
2008), which complement the prognostic 
models mentioned above on source-to-dose 
relationships (Georgopoulos and Lioy 2006).
Current modeling systems in exposure 
science can characterize processes shown in 
Figure 1, because many environmental mod-
els can simulate the processes and impacts 
of pollutants. For example, the impact of 
the sources of a toxicant could be estimated 
by air or water emissions models. The trans-
port/transformation and accumulation parts 
of the continuum explain both physical and 
chemical processes by using models fre-
quently employed in engineering; included 
are fate and transport models that estimate 
the contaminant concentration at a loca-
tion for a point in time. Again, such models 
do not provide estimates of exposure. The 
exposures are estimated using an exposure 
model; then, by including pharmacokinetic 
processes, one can estimate the time-based 
distribution of the levels (dose) of the toxicant 
and its metabolites in the body. Many types 
of exposure models in use are described by 
Georgopoulos and Lioy (2006). The use of 
such systems for exposure reconstruction was 
mentioned above, and future needs are found 
in Georgopoulos et al. (2009). However, the 
development of innovative models that reduce 
uncertainties in exposure characterizations 
can help reduce uncertainties in the design of 
future observational studies.
The Future: Examples of 
Directions and Uses of 
Exposure Science
Two questions that frequently arise about 
exposure in the fields of environmental health 
sciences and risk management are “What 
does one do with exposure information?” 
and “What role does exposure science play in 
regulation and prevention beyond analyses of 
observational data and their interpretation?”
What does one do with such information? 
Observational exposure information has been 
used to support risk assessment, epidemiology, 
and exposure mitigation. Although each is an 
important activity, none are routinely used to 
prevent the toxicant from becoming a problem 
in the first place. The reason is that although 
toxicologic studies are completed on the mate-
rials used to produce a product, exposure stud-
ies are usually implemented after the toxicant 
has been used in commerce, when contact 
with the contaminant (e.g., asbestos, fuel addi-
tives, lead-laden paints) is occurring among 
segments of the population. For example, in 
risk assessments, the analyses completed in an 
exposure assessment are used to characterize 
the risk of disease within a population. Usually 
these exposures are employed to calculate a 
daily dose. The values are matched with infor-
mation on the hazard of a toxic agent to estab-
lish a potential risk. Of course, this should 
occur before the toxicants are present in envi-
ronmental media and exposure pathways are 
established. However, this process seems to 
occur only in a perfunctory manner by con-
sidering only the most obvious pathway, not 
necessarily at the most important time: before 
a product is introduced into commerce (e.g., 
nanoparticles). The above process should 
include a comprehensive exposure character-
ization before materials are introduced into 
consumer products.
Currently, in the absence of mechanis-
tic or observational exposure data, environ-
mental-quality data (e.g., air and water) are 
used as surrogates for exposure for established 
health standards. Thus, most of the health 
standards are defined in terms of the environ-
mental media concentrations and are indi-
rectly related to exposure. The latter is typically 
accomplished by estimating or evaluating the 
high-end (or theoretically most exposed) indi-
vidual. With the collection of data on actual 
exposures and using them in predictive expo-
sure models, the results can reduce uncertain-
ties and exposure misclassification. One such 
example is the use of environmental-quality 
data in the preliminary evaluation of hazard-
ous waste sites (U.S. EPA 1991). These may 
be fine for a preliminary evaluation; however, 
after the initial or preliminary screening assess-
ment, exposure characterizations are essential 
but not routinely employed during the selec-
tion of remediation options or postremedia-
tion. In many cases, postremediation sampling 
is conducted but does not necessarily provide 
data directly related to postremediation expo-
sure (Lioy and Burke 2010).
A project that included postremediation 
exposure evaluation was completed by the 
Environmental and Occupational Health 
Sciences Institute (EOHSI) and the State of 
New Jersey around chromium sites located 
in residential areas of Hudson County, New 
Jersey. The history of the problem is inter-
esting. From 1905 through 1975, Hudson 
County was a center for chromate production 
and manufacturing, including chrome-plated 
bumpers. Facilities generated > 2 million tons 
of waste until about 1960. Later this waste 
was used as apparent clean fill at residential, 
commercial, and industrial locations. In the 
late 1980s, yellowish hexavalent chromium 
(Cr+6, a carcinogen) crystals appeared on 
walls of homes, schools, and other buildings, 
and there were yellow/green blooms of hexa-
valent chromium outdoors. A photo was pub-
lished by Pellerin and Booker (2000). The 
dust was sampled in many homes that were 
built on or next to land contaminated with 
chromium waste. (Lioy et al. 1992). A variety 
of exposure pathways and levels of chromium 
in urine were examined, and it was found that 
people living in homes adjacent to or on a site 
had higher indoor levels and urine levels of 
total chromium. (Methods were not sensitive 
for Cr+6.) The high levels were attributable to 
resuspended particles, dust blown off the sur-
face of the waste sites with high chromium, 
or chromium tracked indoors by residents, 
friends, and pets. In the end, the approxi-
mately 38 residential chromium sites were 
remediated to the known standard.
Uncharacteristic of most hazardous 
waste cleanups, about a year later the State 
of New Jersey funded the return of EOHSI 
to these homes to complete postremediation 
dust sampling. The results showed that the 
levels of chromium in house dust decreased 
to background levels after this period of time. 
Thus, the measurements successfully tested the 
hypothesis that the primary inhalation and 
ingestion pathways for residential exposure had 
been removed from these neighborhoods after 
remediation (Freeman et al. 1995, 1997). This 
is an example of the need to characterize pre- 
and postremediation exposures and should be 
considered when the United States reautho-
rizes the Superfund program or when other 
countries reevaluate their programs. It is not 
sufficient to complete long-term groundwater 
monitoring alone; it is equally important to 
show the community that there are no high 
exposures in the neighborhood after remedia-
tion. In addition, it is a quantitative measure of 
accountability that can demonstrate the success 
of a remediation and is easily understood.
Drinking water standards in the United 
States and Europe are the closest to exposure 
standards, because they are related primarily 
to the ingestion route of exposure. However, 
human exposure data identified other routes 
of significant exposure to particular pollut-
ants found in drinking water. For example, 
drinking water standards did not take into 
account originally all uses of water in the Lioy et al.
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home including showering, bathing, and food 
preparation. The showering issue was stud-
ied directly by Jo et al. (1990), who actually 
measured the exposure to chloroform that 
had accumulated in shower water as a residual 
from the chlorination process. To the surprise 
of many, the dose from dermal and inhala-
tion exposure during one 10-min shower was 
equivalent to the dose received from drinking 
2 L of water from the same tapwater source 
per day. Thus, those who showered longer and 
more frequently each day would have higher 
exposures. This led to reconsideration of tap 
water as the sole basis for drinking water stan-
dards. It was no longer reasonable to say only 
“Do not drink the water.” In many cases, for 
example, with benzene contamination, one 
should just not use the water. This point is a 
cornerstone for the innovative use of exposure 
science to implement prevention strategies.
The National Ambient Air Quality 
Standards or guidelines in the United States 
and in other countries, respectively, are usu-
ally indirectly related to exposure, because the 
levels are taken at a monitoring site designed 
to be representative of the general location 
of an urban or suburban population and 
not meant to represent actual high or low 
exposures or provide near-fenceline estimates 
of pollutant impacts (NRC 2004). Thus, 
populations at highest risk can be missed 
while attaining compliance with a standard. 
However, the good news is that the use of 
highly uncertain exposure metrics has been 
effectively addressed for ambient fine particu-
late matter and ozone standards (Foley et al. 
2003; U.S. EPA 2008b).
Management and reduction of exposure. 
Observational exposure data and information 
have been used to support risk assessment, epi-
demiology, and exposure mitigation. Although 
each is an important activity, none are rou-
tinely used to prevent toxicants from becom-
ing a problem in the first place. Exposure 
studies are usually implemented after the toxi-
cant has been released into commerce and 
contact is already occurring among segments 
of the general population. There have been few 
instances where efforts and resources have been 
specifically redirected from a small incremental 
exposure to a toxicant source outdoors to a 
larger incremental indoor or personal source 
of exposure to the same agent. This was illus-
trated by Wallace (1989) on the significance of 
benzene exposure from cigarettes versus emis-
sion from automobiles. However, even today, 
the merits of continued benzene reduction 
in gasoline are still under consideration (IEc 
2009). Insufficient attention is being given to 
continued reduction/elimination of benzene 
exposure from tobacco smoke.
Some observational situations and simula-
tion studies of human exposure have prompted 
or re-enforced efforts to intervene and mitigate 
or remove the toxicants—for example, in 
environmental tobacco smoke, asbestos, lead 
in dust, World Trade Center dust, indoor 
pesticides, trihalomethanes, polychlorinated 
biphenyls, polybrominated diphenyl ethers, 
hexavalent chromium, and methyl tert-butyl 
ether in reformulated gasoline (Gurunathan 
et al. 1998; Gustafson et al. 2005; Hawley 
1985; Heinrich et al. 2005; Khoury and 
Diamond 2003; Korrick et al. 2000; Lioy et al. 
1994, 2002, 2006; Wallace 1989; Weisel et al. 
1993; Xu and Weisel 2005). The unfortunate 
aspect of these situations and others is the fact 
that most can be lumped under headings of 
unanticipated or unintended consequences, 
and the subsequent actions taken were nec-
essary to clean up a toxicant or mitigate the 
human health effects rather than prevent 
them. Further, if you examine this brief list 
closely, it includes materials used in personal 
products, fire retardants, construction and 
architectural materials, pesticides, production 
wastes, and fuel additives. Thus, one can come 
in contact with a broad range of toxicants dur-
ing daily activities and associated behaviors, 
and it should be a primary focus for applica-
tions to collect exposure information before 
the release of a product that includes a specific 
toxicant into commerce. In some cases, the 
product would still be necessary, but adequate 
education of the public about exposure needs 
to be provided. It is not sufficient to just list a 
common toxicant as a hazard.
As mentioned above, biomonitoring has 
increased in occupational and environment 
settings (ACGIH 2009; Barr et al. 2005; NRC 
2006). For exposure science, these measure-
ments provide a direct link between exposure 
and the dynamic processes of contact and the 
kinetic processes that define the levels or the 
form of a substance after it has been metabo-
lized and redistributed, bioaccumulated, or 
removed from the body. The use of biomoni-
toring in exposure science is important, 
because the results can identify highly exposed 
or unexposed individuals when compared with 
a population distribution. The CDC has taken 
the step of developing distributions of meas-
ured values for a suite of metals, organics, and 
other species in the blood and urine of individ-
uals within the National Health and Nutrition 
Examination Survey (CDC 2009). These data 
can be used to determine whether population 
members have relatively high or low concen-
trations of a toxicant at the time when the 
samples were taken and analyzed. The results, 
however, must be evaluated in the context 
of the specific exposure and biologic sample. 
For example, a high value of a pollutant does 
not necessarily mean that a person is at high 
risk if the pollutant is rapidly cleared from the 
body (i.e., in minutes to hours). In these cases, 
the elevated level could reflect a single expo-
sure resulting from refueling an automobile 
or stripping furniture, rather than the average 
level of an ongoing exposure. On the other 
hand, a biomarker could reflect long-term bio-
accumulation of a toxicant that could result in 
adverse health effects. Thus, the relevance of 
a single biomarker measure also needs to be 
considered in relation to the type and severity 
of a potential disease end point.
Biomonitoring is frequently included 
as part of observational studies of exposure. 
Examples include NHEXAS, TEAM, pesti-
cide studies on farms and in schools and resi-
dences, and the National Children’s Study 
(NCS), to identify a few (Barr et al. 2005; 
Burse et al. 2000; Hoffmann et al. 2000a, 
2000b; Landrigan et al. 2006; Needham et al. 
2005; Sexton et al. 1995; Wallace et al. 1986). 
However, without other information, the 
results are not easy to interpret for the study 
participants, and they cannot lead directly to 
the implementation of an intervention strat-
egy. As a result, one concern about biomoni-
toring is its utility in epidemiology and risk 
assessment beyond stating that one has been 
exposed and that the levels may be associated 
with a health outcome.
Ideally, biomonitoring requires the collec-
tion of other exposure information to identify 
the routes and the pathways of exposure and 
to eliminate sources. This complex problem 
has led to research programs that are beginning 
to develop theoretical reconstructive model-
ing tools to retrace the biomonitoring results 
backward to the routes of exposure. Inversion 
algorithms are required that include pharmaco-
kinetic processes associated with the time 
course of accumulation of a toxicant. The goal 
is to eventually use many of these biomarkers 
as public health standards, which are coupled 
with other exposure information to achieve 
successful interventions (Dixon et al. 2009; 
Freeman et al. 2001a, 2001b; Rhoads et al. 
1999; Weis et al. 2005). The example most fre-
quently referred to is blood lead (CDC 1991; 
Dixon et al. 2009; Freeman et al. 1997; NRC 
1993). A current and future challenge will be 
how the combination of biomonitoring, in-
home measurements, and extant environmental 
data [as assembled and integrated in a exposure 
index (EI)] can be linked effectively to define 
exposures in the NCS (Lioy et al. 2009).
Another type of observational study that 
can be used to improve risk characterization 
and reduction is the simulated observational 
exposure study. Simulated exposure studies use 
scripted technician activities in locations rep-
resentative of potentially high-exposure situa-
tions. Thus, the exposures simulate reality, but 
they are being measured by a scripted worker 
and not a volunteer subject. Other examples 
would be estimates of dietary intake of toxi-
cants measured in foods bought at the grocery 
store and toxicants found in a local water sup-
ply. Simulation tools were employed in the Exposure science past and future
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1980s to examine dermal retention of pesti-
cides using a fluorescent tracer (Fenske et al. 
1986a, 1986b) and later to simulate automo-
bile exposure by tracking measurements in a 
car cabin during repeated drives along a stretch 
of highway (Lawryk and Weisel 1996, Stieb 
et al. 2008).
For inhalation exposures, the release of 
inert tracer gases, for example, perfluorocarbon 
tracers in an area of concern for exposure, such 
as a busy street canyon (Lioy et al. 2007), is an 
effective tool. On release of a tracer, technicians 
use scripted activities to represent potential pat-
terns of exposure over a defined period of time, 
including before, during, and after a release. 
The results are analyzed for location and inten-
sity of contact over time. The article (Lioy et al. 
2007) discusses use of the technique in home-
land security and disaster response situations. 
It can be used to estimate the potential mag-
nitude of exposure to people in harm’s way 
and the potential hot-zone areas for emergency 
responders and the general public. It is a tech-
nique that still needs development, as discussed 
by Rodes et al. (2008), because it can also be 
employed to examine near-roadway exposures. 
It is important to make sure that the scripted 
techniques are selected after careful consider-
ation of the population whose exposure is to be 
evaluated in a study.
What role does exposure science play in 
situations beyond observational analyses and 
their interpretation? The answer to this ques-
tion encompasses new directions for exposure 
science research and enhances the contribu-
tions of exposure science to risk management 
and prevention programs in all countries. More 
important, the answer will also move the basic 
science components of the field to include 
anticipatory or intervention research and engi-
neering and will require a heavy emphasis on 
source-to-dose modeling (Lioy 1998). This new 
direction will focus on minimizing the poten-
tial impact of unanticipated or unintended 
consequences or poorly designed products or 
applications on the general public or the gen-
eral population.
The fundamental science issue is to under-
stand contact, but the ultimate goal is to pre-
vent exposures by examining the potential for 
contact and exposure before large-scale contacts 
among members of the general public occur. 
The approach includes some aspects of the pre-
cautionary principle, because the results will be 
used to prevent severe or irreversible harm to 
the public. This does not mean, however, that 
studies will deliberately expose individuals to 
products or the constituents of products before 
they are introduced to the market. Such studies 
are unethical and just poor science. The goal 
is proactive in nature such that the research 
would be designed to achieve the scientific 
consensus needed to show that significant 
harm would not occur using the product made 
with the specific chemical or other material 
before it is placed in commerce. This would be 
in contrast to the current practice of looking 
at emissions after the materials are in com-
merce, such as in recent studies by Gewurtz 
et al. (2009) that examined perfluoroalkyl con-
taminant emissions during carpet installation 
and by Imm et al. (2009) that examined the 
release of PBDEs from products currently used 
in homes.
A proactive exposure science research 
agenda to improve product certification by 
minimizing releasable toxicants would pre-
vent contact before it can occur. Such 
research would involve completing simula-
tions of potential emissions during the rou-
tine use of the product when new or as it 
ages, including scenarios for actual product 
use and not just within the manufacturer’s 
suggested guidelines. The results could couple 
source-to-  exposure models with dose models 
to determine the potential impact on humans 
from acute or long-term exposures. The latter 
would employ the knowledge obtained from 
observational studies on activities and behav-
ior to simulate contacts with new materials 
or products prior to introduction into com-
merce. The efforts would focus on prevention, 
not post  production mitigation.
In some ways, the seeds have already been 
planted to implement this approach; how-
ever, currently there is no systematic effort to 
implement such a procedure by industry and 
governments around the globe. For example, 
there have been testing programs for emissions 
of various compounds by materials used in 
construction and architectural uses and home 
products [ANSI (American National Standards 
Institute) 2007; ASTM (formerly American 
Society for Testing and Materials) 2006; 
California Department of Health Services 
(CAL/DHS) 2004; European Committee for 
Standardization 2002]. Further, we under-
stand many of the behaviors and activities that 
lead to exposure. However, at the present time 
these approaches are not used in combination 
within carefully designed testing programs to 
prevent exposures.
The following is a very simple hypothetical 
example of a prospective approach that uses 
information and tools from toxicology, expo-
sure science, and hazard assessment. Issue: A 
semivolatile material, X, is being considered 
for use in a commercial product.
First, the following baseline toxicologic 
considerations are needed to frame the poten-
tial exposures:
•	What is the toxicology and hazard of X 
compound in its raw form?
•	Will it remain as compound X or be trans-
formed to an intermediate or another com-
pound in final form; in the transformed 
state, what are the added acute or long-term 
hazards?
The question becomes, Is the material 
of such a highly toxic nature that it should 
not even be considered for the intended 
use—a consideration that is currently part 
of the European Regulation for Registration, 
Evaluation, Authorization and Restriction 
of Chemicals (REACH) objectives (Van der 
Wielen 2007). This would seem to be an obvi-
ous requirement, but there are many examples 
of the failure to consider this in product devel-
opment. Examples are lead-bearing pigments 
in paints applied to children’s toys, lead-laden 
paint in artificial turf products, outdoor resi-
dential mosquito misters, and formaldehyde in 
home insulation. REACH is actually develop-
ing exposure scenarios that should cover the 
life cycle of a toxicant, including exposure to 
the consumer [European Chemicals Agency 
(ECHA) 2008].
The next steps would be the proactive 
exposure science evaluation. This would be 
accomplished by a) determining the form of 
the final product, and how it will be used, 
and b) developing a protocol to test the prod-
uct under typical use conditions (new and 
the aged product). Included would be the co-
emission or release with other materials in the 
product. The plan would be to
•	Conduct	experiments	on	direct	emissions	of	
the compound X and transformed products 
for various uses, and their mobility.
•	Couple	emission	results	with	typical	activi-
ties and a variety of behaviors to estimate 
exposure during product use.
Depending on the material, the above 
activities include air emissions tests and der-
mal- or ingestion-related contacts. In the case 
of compound X, this would be air emissions or 
surface deposition. Further, the controlled tests 
for release and exposure need to be designed 
and conducted on both new and used prod-
ucts for the behaviors and activities of interest.
Final steps in the process would be to 
a) apply the results to exposure-to-dose mod-
els, similar to the Modeling Environment for 
Total Risk (MENTOR) approach (Figure 2) 
(Georgopoulos 2008), but simplified and 
standardized for product evaluations, and 
b) define the potential contact and exposure 
to compound X or final form.
The source-to-dose modeling should 
extend the results to typical and extreme con-
ditions of use to examine the potential for 
acute exposure and long-term exposure. The 
estimated exposures need to be translated into 
estimated doses and used in conjunction with 
hazard assessments to determine the potential 
for excessive acute or long-term risks.
This simple example can have many poten-
tial permutations and a range in approaches 
for use with individual products. This 
approach to exposure science is clearly pro-
active and for the express purpose of preven-
tion. Further, it links exposure science directly Lioy et al.
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to the outcomes of toxicologic studies and 
hazard assessments. Over the years, too many 
compounds with great intrinsic value have 
been removed because of occupational or envi-
ronmental exposure. That situation probably 
could have been avoided had the applications 
been limited to very specific and high-value 
applications designed to minimize the risk for 
acute or chronic health outcomes. The good 
news is that the technology is available or can 
be developed to minimize risk in specific situ-
ations, and the chemical industry has become 
much better at determining which chemicals 
are highly toxic. The problem is the lack of a 
framework that is acceptable to government 
agencies and translatable across industrial sec-
tors that can be systematically applied before 
products are delivered to the marketplace. A 
current product problem is Chinese wallboard 
used in residential settings (Congressional 
Record 2009).
Finally, the above example would not 
eliminate the need for observational studies; 
however, they could be employed more judi-
ciously to resolve legacies and conditions asso-
ciated with current products on the market 
and prevent the inevitable unintended conse-
quence of accidental or deliberate exposures.
Conclusions
The field of exposure science has many tools 
to observe and characterize exposure for 
epidemiologic studies and risk assessments. 
Further, the field provides fundamental infor-
mation needed to understand the dynam-
ics and kinetics of contact and the resulting 
occupational or environmental exposures. The 
approaches have improved significantly since 
the early 1980s and continue to build on a 
scientific foundation based on theoretical and 
laboratory studies. The need to link exposure 
science to risk management and intervention 
is well known, but additional resources are 
required to ensure that the field plays a more 
pivotal role in preventing or mitigating expo-
sures. This will also lead to better simulation 
protocols and models to characterize con-
tact under many types and varieties of con-
ditions before they occur as well as increase 
the use of exposure science regulatory strate-
gies that prevent contact across populations 
stratified by age, sex, susceptibility, and cul-
ture, thus stimulating innovation. Focused 
and more enriched observational studies can 
be designed to evaluate models and improve 
the understanding of the levels of contact and 
the intensity of exposure in populations, for 
example, the NCS. Eventually, the general 
uses of exposure research will be appreciated 
as more than as a support tool for epidemiol-
ogy or risk assessment. However, resources 
specifically directed toward exposure science–
related research and training is needed to 
make this potential a reality.
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